These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7775521)

  • 1. Safety, feasibility and long term follow-up of a non-thoracotomy defibrillation system in patients with inducible sustained ventricular tachycardia/fibrillation.
    Gielchinsky I; Rothbart ST; Parsonnet V; Hussain SM; Fuzesi L; Fontana CA; Checchio T; Neglia D
    J Cardiovasc Surg (Torino); 1994 Dec; 35(6 Suppl 1):111-3. PubMed ID: 7775521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results and experiences of transvenous endocardial defibrillator therapy].
    Trappe HJ; Fieguth HG; Weber-Conrad O; Schöhl W; Wahlers T; Kielblock B; Wenzlaff P; Klein H; Lichtlen PR
    Med Klin (Munich); 1992 Dec; 87(12):615-21. PubMed ID: 1287422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Initial clinical results with a novel implantable cardioverter-defibrillator: a prospective evaluation in 3 Swiss university hospitals].
    Osswald S; Candinas R; Fuhrer J
    Schweiz Med Wochenschr; 1995 Dec; 125(50):2423-32. PubMed ID: 8553030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The subcutaneous array: a new lead adjunct for the transvenous ICD to lower defibrillation thresholds.
    Higgins SL; Alexander DC; Kuypers CJ; Brewster SA
    Pacing Clin Electrophysiol; 1995 Aug; 18(8):1540-8. PubMed ID: 7479175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Implantation of defibrillators with transvenous-subcutaneous electrode systems].
    Hief C; Podczeck A; Veit F; Frohner K; Kaltenbrunner W; Nürnberg M; Steinbach K
    Wien Klin Wochenschr; 1993; 105(1):12-6. PubMed ID: 8438594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].
    Block M; Hammel D; Borggrefe M; Scheld HH; Breithardt G
    Herz; 1994 Oct; 19(5):259-77. PubMed ID: 8001899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized evaluation of a nonthoracotomy implantable cardioverter defibrillator lead system. Endotak/PRX Investigator Group.
    Baker JH; Epstein AE; Voshage-Stahl L
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):72-8. PubMed ID: 9121974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with transvenous implantable cardioverter-defibrillators for treatment of malignant ventricular arrhythmias.
    Jadonath RL; Pogo GJ; Goldner BG; Kalenderian D; Merkatz K; Cohen MB; Snow JS; Cohen TJ
    J Invasive Cardiol; 1995 Apr; 7(3):72-9. PubMed ID: 10155366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with two different nonthoracotomy systems for implantable defibrillator in 170 patients.
    Sra JS; Natale A; Axtell K; Maglio C; Jazayeri M; Deshpande S; Dhala A; Blanck Z; Akhtar M
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 1):1741-50. PubMed ID: 7838782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Short-term and long-term outcome of left heart function after cardioverter defibrillator implantation].
    Takeichi K; Kasanuki H; Ohnishi S; Endoh Y; Hosoda S
    J Cardiol; 1996 Nov; 28(5):277-86. PubMed ID: 8953401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Italian multicenter clinical experience with endocardial defibrillation: acute and long-term results in 307 patients. The Italian Endotak Investigator Group.
    Raviele A; Gasparini G
    Pacing Clin Electrophysiol; 1995 Mar; 18(3 Pt 2):599-608. PubMed ID: 7777424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [10 years of therapy with implantable defibrillators--observation in 353 patients].
    Trappe HJ; Wenzlaff P; Klein H; Pfitzner P; Fieguth HG; Kielblock B; Lichtlen PR
    Z Kardiol; 1995 Mar; 84(3):222-31. PubMed ID: 7732715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival and complications in patients with malignant ventricular tachyarrhythmias: treatment with a nonthoracotomy implantable cardioverter defibrillator with or without a subcutaneous patch.
    Jafar MZ; Schloss EJ; Mehdirad AA; Keim S; Rist K; Siddiqui S; Tchou PJ
    Pacing Clin Electrophysiol; 1997 May; 20(5 Pt 1):1305-11. PubMed ID: 9170131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with the transvenous Medtronic Pacer Cardioverter Defibrillator (PCD) System.
    Golino A; Pappone C; Panza A; Santomauro M; Iorio D; De Amicis V; Chiariello M; Spampinato N
    Tex Heart Inst J; 1993; 20(4):264-70. PubMed ID: 8298322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.